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Abstract (#1058)
BACKGROUND:  Loss to follow-up (LTF) from HIV care has been linked to multiple negative 
health outcomes, including virologic failure, disease progression and reduced survival. We 
sought to elaborate the primary epidemiologic factors associated with LTF among patients 
newly enrolled in an urban, hospital-based outpatient HIV program.  
METHODS:  We completed a retrospective medical record review of all new patients 
presenting for care between 2005 and 2008. LTF was defined as an interruption between 
medical visits of more than 180 days. Alpha was set at <0.05 with a 95% CI.  Bivariate analyses 
were performed using SPSS 15.0 (IBM, Inc., Chicago, IL).   
RESULTS:  Among the 321 patients included in the analysis, three groups were identified: 
patients without lapses in medical visits (No LTF; 37%); patients intermittently LTF who 
later returned to care (ILTF; 30%), and patients permanently lost to follow-up (PLTF; 33%). 
Demographic variables associated with PLTF included younger age (p=0.033) and residence in 
a medical, corrections or rehabilitation facility (p=0.012). Other significant risk factors included 
prior incarceration (p=0.012), reported use of alcohol and/or recreational drugs (p=0.015), and 
evidence of anxiety or depression on routine screening at program intake (p=0.016 and 0.005, 
respectively). A transmission risk factor of injection drug use (IDU) was associated with PLTF 
(p=0.002), while a CD4 count less than 100 at program entry correlated with increased retention 
in care (p=0.035). Conditioned bivariate analyses demonstrated reduced engagement occurring 
more commonly among young African Americans (p=0.026), White, non-Hispanic IDU (p<0.001) 
and women with histories of arrest (p=0.036) and incarceration (p=0.036). Conditioned bivariate 
analyses demonstrated reduced engagement occurring more commonly among young Black/
African Americans (p=0.026), White, non-Hispanic IDU (p<0.001) and women with histories of 
arrest (p=0.036) and incarceration (p=0.036). 
CONCLUSION:  LTF is an all-too-common phenomenon in HIV care with potentially significant 
consequences for patients. Multiple clinical, demographic and psychosocial factors are 
associated with suboptimal retention in care. Special strategies to enhance the engagement of 
patients at highest risk for LTF are warranted.  
•	 Loss to follow-up is an all-too-common phenomenon among patients newly enrolled in 
care, with more than half of these individuals exhibiting unexplained absences greater 
than 180 days during six years of observation.
•	 Since LTF has been associated with multiple detrimental health outcomes, special 
strategies to enhance the engagement of HIV patients at highest risk for LTF are 
warranted.  
•	 Prospective studies assessing the impact of programmatic interventions to improve 
patient retention rates are desperately warranted. 
Conclusions
Background
•	 Many HIV-infected Americans have failed to reap the benefits of current HIV therapies 
because of suboptimal rates of diagnosis, linkage, engagement and retention.1 
•	 Non-adherence with medical visits has been associated with multiple undesirable 
outcomes:
	 	 	 –	 	lower	CD4	counts	and	higher	viral	loads2	
	 	 	 –	 	delays	in	virologic	suppression	and	increased	HIV	viral	load	burden3	
	 	 	 –	 	virologic	failure4	
	 	 	 –	 the	development	of	AIDS-defining	illnesses5	
	 	 	 –	 	reduced	survival5-11	
•	 Previous studies have coupled several clinical, demographic and psychosocial factors 
with the phenomenon of patient loss to follow-up (LTF). 
•	 We aimed to establish the incidence of LTF and identify the correlates of LTF among 
patients newly enrolled in care at the AIDS Activities Office (AAO) of Lehigh Valley 
Health Network, an urban, multidisciplinary primary care practice for almost 800 HIV-
infected patients in Allentown, PA.
Methods
•	 Completed retrospective chart review of medical and case management records of all 
new patients enrolling into care between January 2005 and June 2008 (n=321)
•	 Calculated number of days between 
consecutive medical visits from 2005 to 2010
•	 “Loss to Follow-up” (LTF) defined as any 
unexplained interrruption between medical 
visits of greater than 180 days.
•	 Potential correlates of LTF examined through 
bivariate and conditioned bivariate analyses using SPSS 15.0 (IBM, Inc., Chicago, IL). 
	 	 	 –	 	Alpha	set	at	<0.05	with	a	95%	CI.	
•	 Study approved by Institutional Review Board of Lehigh Valley Health Network. 
•	 More than 60% (201/321) of newly enrolled 
patients had at least one episode of LTF during the 
six years of observation. (Table I)
	 	 	 –	 48%	(96/201)	were	ultimately	reengaged	in	care	(ILTF).
	 	 	 –	 	Patients	with	a	single	medical	visit	accounted	for	43%	
of	the	PLTF	group.
•	 Several factors increased the risk of interrupted 
patient engagement (p<0.05). (Table II)
	 	 	 –	 Demographic:	Age	<	43	years
	 	 	 –	 Psychosocial:	
	 	 	 	 	 •	 	Reported	use	of	alcohol,	recreational	drugs	and	
nicotine
	 	 	 	 	 •	 	History	of	incarceration
	 	 	 	 	 •	 	Temporary	residence	in	a	medical,	corrections	or	
rehabilitation	facility	(almost	80%	with	some	visit	gap	
and	59%	with	PLTF)
	 	 	 	 	 •	 	Screening	indicating	significant	anxiety	or	depression	
at	program	intake	(enrollment	in	psychiatric	services	
was	not	predictive).
	 	 	 –	 Clinical:	HIV	transmission	via	injection	drug	use
•	 Low baseline CD4 count (<100 cells/mL) was 
associated with sustained retention in care. 
•	 Surprisingly, patients with lower incomes were less 







•	 The following factors were not statistically correlated 
with LTF:
	 	 	 –	 Baseline	Viral	Load
	 	 	 –	 	New	HIV	or	AIDS	Diagnosis
	 	 	 –	 Zip	Code/Proximity	to	Practice
	 	 	 –	 	Method	of	Transportation
	 	 	 –	 Marital	Status
	 	 	 –	 	Children	Age	<18	years	at	Home
	 	 	 –	 Education	Level
	 	 	 –	 	Employment	Status
	 	 	 –	 History	of	Arrest
	 	 	 –	 	Insurance	Status
	 	 	 –	 Enrollment	in	Mental	Health	Program
	 	 	 –	 	Learning	Impairments
	 	 	 –	 	Probation	or	Parole	at	Intake
•	 Conditioned bivariate analysis revealed unique sub-
groups with heightened risk for LTF: (Table III)
	 	 	 –	 Non-Hispanic	White	Females
	 	 	 –	 	Non-Hispanic	Blacks	<43	years
	 	 	 –	 	Non-Hispanic	Whites	with	a	history	of	drug/alcohol	use
	 	 	 –	 Females	with	histories	of	arrest	or	incarceration




No Loss to Follow-up No LTF Patients without any unexplained lapse in medical care >180 days
Intermittent LTF ILTF Patients intermittently lost to follow-up (>180 days) who later return to care
Permanent LTF PLTF Patients permanently lost to follow-up during analysis
* 45/105 PLTF patients (42.8%) only had a single medical visit. 
Table I. Frequency of Loss to Follow-up Among Newly Enrolled Patients
N Percent




**HADS=Hospital Anxiety and Depression Scale
Table II. Analysis of Factors Potentially Associated with Loss to Follow-up Among New Patients
 Variables N No LTF ILTF PLTF p Value
% N % N % N
Gender 319        
    Female  38% 38 27% 27 35% 35 .670
    Male  37.4% 82 31.5% 69 31.1% 68
Age (Quartiles) 321
    16-37 36% 32 24.7% 22 39.3% 35 .033
    38-43 27.6% 21 32.9% 25 39.5% 30
    44-49 39.5% 30 39.5% 30 21.1% 16
    50-73 46.3% 37 23.8% 19 30% 24
Race/Ethnicity 316
    White Non-Hispanic 43.5% 47 24.1% 26 32.4% 35 .280
    Black Non-Hispanic 34.4% 30 35.6% 31 29.9% 26
    Hispanic  32.2% 39 31.4% 38 36.4% 44
Initial CD4 Count 309
    <=100 55.4% 41 27.0% 20 17.6% 13 .035
    101 - 200  32.3% 10 25.8% 8 41.9% 13
    201 - 350 29.0% 18 38.7% 24 32.3% 20
    351 - 500 33.9% 19 30.4% 17 35.7% 20
    501 + 33.7% 29 30.2% 36 36.0% 31
Transmission Status 309
    Heterosexual 37.4% 58 29.7% 46 32.9% 51 .002
    MSM 47.9% 45 31.9% 30 20.2% 19
    IDU 21.7% 13 28.3% 17 50% 30
Drug/ETOH Use (Not Nicotine) 243
    Yes 30.6% 48 31.8% 50 37.6% 59 .046
    No  39.5% 34 38.4% 33 22.1% 19
Drug/ETOH Use (Inc. Nicotine) 245
    Yes 30.1% 53 32.4% 57 37.5% 66 .015
    No 43.5% 30 37.7% 26 18.8% 30
Living Situation 230
    With Parents or Family 34.6% 27 41.0% 32 24.4% 19 .012
    With Spouse/Partner 40.0% 26 36.9% 24 23.1% 15
    Alone/Roommate 32.1% 17 34.0% 18 34.0% 18
    Institution/Treatment Ctr 20.6% 7 20.6% 7 58.8% 20
Poverty Status 280
    < Federal Poverty Level 42.1% 96 30.3% 69 27.6% 63 .009
    100-200% Poverty Level 57.7% 15 42.3% 11 0% 0
    >200% 26.9% 7 50.0% 13 23.1% 6
History of Incarceration 216
    Yes 23.5% 19 33.3% 27 43.2% 35 .012
    No 40.0% 54 34.1% 46 25.9% 35
Anxiety Score (HADS)** 252
    Low (0 - 7) 42.4% 50 42.4% 50 15.3% 18 .016
    Moderate (8 - 10) 41.3% 19 37.0% 17 21.7% 10
    High (11 - 21) 40.9% 36 25.0% 22 34.1% 30
Depression Score (HADS) ** 252
    Low (0 - 7) 38.6% 61 39.9% 63 21.5% 34 .005
    Moderate (9 - 10) 62.0% 31 22.0% 11 16.0% 8
    High (11 - 21) 29.5% 13 34.1% 15 36.4% 16
Table III. Conditioned Bivariate Analysis of LTF Among New HIV Patients
 Variables N No LTF ILTF PLTF p Value
% N % N % N
Gender* Race/Ethnicity 314        
    White Non-Hispanic  
    Female  30.0% 6 10.0% 2 60.0% 12 .012
    Male  46.6% 41 27.3% 24 26.1% 23
    Black Non-Hispanic Not Significant
    Hispanic Not Significant
Age* Race/Ethnicity 316
    White Non-Hispanic Not Significant
    Black Non-Hispanic
    16-37 23.8% 5 38.1% 8 38.1% 8 .026
    38-43 19.0% 4 33.3% 7 47.6% 10
    44-49 33.3% 7 52.4% 11 14.3% 3
    50-73 58.3% 14 20.8% 5 20.85 5
    Hispanic  Not  Significant
Transmission Status* Gender 309
    Female
        Heterosexual 44.4% 32 26.4% 19 29.2% 21 .042
        IDU 19.0% 4 23.8% 5 57.1% 12
    Male
        Heterosexual 31.3% 26 32.5% 27 36.1% 30 .005
        MSM 48.9% 45 32.6% 30 18.5% 17
        IDU 23.1% 9 30.8% 12 46.2% 18
Transmission Status* Race/Ethnicity 309
    White Non-Hispanic        
        Heterosexual 30.8% 12 28.2% 11 41% 16 .001
        MSM  57.9% 33 24.6% 14 17.5% 10
        IDU 10.0% 1 10.0% 1 80.0% 8
    Black Non-Hispanic  Not Significant
    Hispanic Not Significant
 Drug/Alcohol Use* Race Ethnicity (exc. 
Nicotine) 239
      
    White Non-Hispanic         
        Yes 36.4% 16 18.2% 8 45.5% 20 .014
        No 45.8% 11 41.7% 10 12.5% 3
    Black Non-Hispanic Not Significant
    Hispanic Not Significant
Arrest or Incarceration* Gender 244
    Female        
        Prior Arrest 23.8% 10 33.3% 14 42.9% 18 .036
        No Prior Arrest 51.4% 18 25.7% 9 22.9% 8
    Male Not Significant
    Female
        Prior Incarceration 20.0% 4 25.0%  5 55.0% 11 .036
        No Prior Incarceration 47.6% 20 28.6% 12 23.8% 10
    Male Not Significant
Arrest or Incarceration* Race/Ethnicity 213
    White Non-Hispanic       
        Yes 24.4% 10 31.7% 13 43.9% 18 .012
        No 57.5% 15 26.9% 7 15.4% 4
    Black Non-Hispanic Not Significant
    Hispanic Not Significant
